A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
Clinical trial NCT03139513 · COMPLETED
Trial details
- NCT number
- NCT03139513
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-27
- Primary completion
- 2018-08-22
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.